Is Novonix's 80% share price crash in 2022 justified?

There might be good reason for the unceremonious collapse of the Novonix share price.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Novonix share price has imploded by 80% in 2022
  • Part of the major sell-off could be the widening losses in a world where capital is becoming more expensive
  • Novonix has still achieved some notable milestones this year

The Novonix Ltd (ASX: NVX) share price has experienced a destructive share price crash of 80% during 2022. This dramatic drop in value has left many investors wondering if the crash is justified, and what could have caused such a steep decline.

One possibility is that Novonix's financial performance has not lived up to expectations. Typically, a difference between market expectations and reality can only be sustained for so long before investors react.

The Novonix share price entered the year with its chest puffed out — parading a $10.52 price tag. Exactly 353 days later, the scenery isn't as picturesque for the battery technology company. Today, shares in the same company are swapping hands at $1.73, as displayed above.

Sad investor watching the financial stock market crash on his laptop computer.

Image source: Getty Images

Is there a good reason for the punishment?

It's worth taking a closer look at Novonix's financial performance to see if this is a possible reason for the share price crash.

According to the company's financial statements, Novonix has seen accelerating revenue growth in recent years. From FY20 to FY21, Novonix increased its revenue by 28% to $5.23 million. Amping up the growth, revenue grew by 61% in FY22.

However, the company's bottom line has significantly deteriorated in the current year. In an environment where capital is becoming more expensive, it wouldn't be a surprise if investors became less bullish on Novonix as its losses widened. Losses in FY22 totalled $71.44 million, taking a gigantic leap deeper from $18.08 million in the prior year.

Novonix finished the September ending quarter with $181.77 million of cash on hand. Although, with a worsening cash burn, shareholders might be concerned about future dilution if the company fails to navigate to positive cash flow with its current capital.

It's also worth considering whether the overall market conditions played a role in Novonix's share price crash. Novonix fits somewhere in between a tech share and a battery material share. While battery material producers — such as ASX lithium shares — have generally performed well this year, tech shares have had a miserable run.

Novonix share price walloping warranted?

So, is Novonix's 80% share price crash justified? It's difficult to say for certain without the benefit of hindsight. Even now, the company could appear richly valued given its trading at 102 times revenue for the trailing 12 months.

On the flip side, many non-financial achievements were obtained during the year. These include:

  • Securing a graphite supply agreement with KORE Power
  • Entering negotiations with the US Department of Energy for US$150 million of funding
  • Constructed and opened multiple manufacturing and testing facilities

The above developments are encouraging for long-term investors. However, the market has shown that it wants profits to support a rich valuation. The Novonix share price could risk further declines if the company continues to churn through its capital.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why Brainchip, Fortescue, IGO, and Life360 shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

a woman sits next to her computer screen with her head in her hands with the screens slowing graphs on downward trajectories.
52-Week Lows

Can the beaten-down CSL share price ever reach $300 again?

CSL is near decade lows. Can it ever climb back?

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Black Cat, Mirvac, Qantas, and Temple & Webster shares are falling today

These shares are having a tough session. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Bank of Queensland, Cochlear, Northern Star, and Paladin Energy shares are falling today

These shares are having a difficult time on hump day. But why?

Read more »

An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.
Share Fallers

Why ANZ, Challenger, Hub24, and Lynas shares are dropping today

These shares are under pressure on Tuesday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Monash IVF, NAB, Viva Energy, and Worley shares are falling today

These shares are starting the week in the red. But why?

Read more »